Related Experiment Videos
Routine meconium screening versus drug screening per physician order: detecting the true incidence of drug-exposed
1Columbia-Augusta Medical Center, GA, USA.
Insights
Widespread prenatal drug exposure is a concern. Universal meconium screening significantly increased detection rates, yet few mothers accepted rehabilitative services, emphasizing the need for prevention programs.
Area of Science:
- Neonatal Abstinence Syndrome
- Perinatal Substance Abuse
- Public Health
Background:
- National statistics show 11% of newborns exposed to drugs in utero.
- Previous screening methods (physician's order via blood/urine) yielded low positive rates (0.2%).
Purpose of the Study:
- To evaluate the effectiveness of universal meconium screening for in utero drug exposure.
- To assess the uptake of rehabilitative services among mothers identified through screening.
Main Methods:
- Implemented universal meconium screening for all newborns during July-November 1994.
- Compared results with historical data using physician-ordered blood and urine screens (1993, 1995).
Main Results:
- Universal meconium screening identified a 4.5% positive rate for in utero drug exposure.
- This rate is significantly higher than the 0.2% detected via targeted screening.
- Only 2 out of 22 mothers (9%) with positive screens accepted rehabilitative services.
Conclusions:
- Universal meconium screening dramatically increases the detection of prenatal drug exposure.
- Low uptake of rehabilitative services highlights a critical gap in maternal care.
- Early educational programs focused on prevention are essential to address this public health issue.
Abstract:
National statistics indicate that 11% of newborns are exposed to drugs of abuse in utero (Chasnoff, Burns, Schnoll, & Burns, 1985). From July through November of 1993, 0.2% (1/583) of infants in our hospital screened positive for exposure to drugs of abuse in utero, by blood and urine screens collected per physician's order. During the same 4 months in 1995, 0.2% (1/574) screened positive. In contrast, from July through November 1994, all newborns born at our institution were screened for in utero drug exposure using meconium samples; approximately 4.5% (22/493) were positive. Meconium screening of all infants, not just those per physician order, produced a dramatic increase in positive drug results. Of great concern in this study was that only two of the 22 mothers identified as having drug-screen positive babies during the 1994 meconium screening agreed to use rehabilitative services. This highlights the necessity of intervention through early educational programs stressing prevention.